ACR Leaders at ECR 2026
ACR leaders showcased advances in radiology AI and global programs driving safe adoption, quality assurance and international collaboration.
Read moreACR Data Science Institute’s AI Central has been updated with three new Transparent-AI products and three new products to the directory.
Three new products were added to our Transparent-AI program, which is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population.
Perspectum Diagnostics Ltd. joined the Transparent-AI program with their products MRCP+, Hepatica, and LiverMultiScan.
Transparent-AI consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with three new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see newly cleared FDA products designed for pediatric x-rays, chest CTs and prostate MR images.
New products include:
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Cardiac CT Function Software Application
ACR Leaders at ECR 2026
ACR leaders showcased advances in radiology AI and global programs driving safe adoption, quality assurance and international collaboration.
Read moreACR Encourages Flexibility in HHS Information Blocking Rules
ACR urges HHS to maintain AI transparency rules and adopt a requestor‑preference exception to support patient‑directed access to health data.
Read moreACR Provides Policy Guidance to HHS on Clinical AI
ACR recommended stronger AI oversight, more research funding, and sustainable Medicare payment to support safe clinical AI adoption.
Read more